Automated Cell Cultures Market Report 2026

Automated Cell Cultures Market Overview

• Automated Cell Cultures market size has reached to $7.02 billion in 2025 • Expected to grow to $11.58 billion in 2030 at a compound annual growth rate (CAGR) of 10.5% • Growth Driver: Growth In Biopharmaceutical Production Driving Expansion In Automated Cell Culture Market • Market Trend: The Rise Of AI-Powered Automated Cell Culture Systems In Drug Discovery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Automated Cell Cultures Market?

Automated cell cultures refer to the use of automated systems and robotics to perform cell culture tasks, such as seeding, feeding, and harvesting cells. These systems reduce manual labor, improve reproducibility, and enhance the scalability of cell culture processes. Automation in cell culture helps maintain sterile conditions and consistent results. The main types of automated cell cultures are modular automation and whole-label automation. Modular automation refers to the use of consolidated, integrated, pre or post-analytical automation modules in laboratories to streamline workflows and increase efficiency. The equipment types are automated liquid handling systems, microplate readers, robotic systems, automated storage and retrieval systems, and others, and their applications include biopharmaceuticals production, diagnostics, gene therapy, drug screening and development, toxicity testing, stem cell research, tissue engineering and regenerative medicine, personalized medicine, and others. It is used by various end users, such as pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, research institutes, and cell banks.

What Is The Automated Cell Cultures Market Growth Forecast?

The automated cell cultures market size is expected to see rapid growth in the next few years. It will grow to $11.58 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing investments in cell and gene therapy manufacturing, rising demand for high-throughput screening, expansion of personalized medicine research, growing adoption of automation in laboratories, increasing focus on scalable biologics production. Major trends in the forecast period include increasing deployment of fully automated cell culture platforms, rising adoption of robotic liquid handling systems, growing use of scalable cell culture automation, expansion of closed-system cell processing, enhanced focus on reproducibility and sterility control.

What Is The Driver Of The Automated Cell Cultures Market?

The increasing the production of biopharmaceuticals is expected to propel the growth of the automated cell cultures market going forward. Biopharmaceuticals are medical drugs produced using biotechnology methods, including recombinant DNA technology and cell culture techniques. The growing demand for biopharmaceuticals is driven by their ability to offer targeted, effective treatments with fewer side effects compared to traditional therapies. Automated cell culture enhances efficiency and consistency in biopharmaceutical production by streamlining cell growth, monitoring, and harvesting processes. For instance, in July 2025, according to Sartorius, a Germany-based international life science technology company, global sales of biopharmaceutical drugs rose by about 9% to reach USD 458 billion in 2024, up from the previous year, accounting for 41% of the total pharmaceutical market compared with 40% in 2023. Therefore, increasing the production of biopharmaceuticals is driving the growth of the automated cell cultures industry.

Key Players In The Global Automated Cell Cultures Market

Major companies operating in the automated cell cultures market are Hitachi Ltd., Panasonic Holdings Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group AG, Nikon healthcare, Sartorius AG, Beckman Coulter Inc., Celltrio Inc., Eppendorf AG, Tecan Trading AG, Shibuya Corp, Hamilton Company, Molecular Devices LLC, FORMULATRIX, Highres Biosolutions, Biotron Healthcare, Agilent Technologies, Miltenyi Biotec

Global Automated Cell Cultures Market Trends and Insights

Major companies operating in the automated cell cultures market are focusing on technological advancements such as integrated artificial intelligence (AI)-powered software to gain a competitive advantage. Integrated AI-powered software in automated cell culture optimizes experimental conditions and enhances efficiency by analyzing real-time data to improve cell growth and productivity. For instance, in October 2023, Molecular Devices LLC, a US-based biotechnology company, launched the CellXpress.ai Automated Cell Culture System, a groundbreaking innovation aimed at enhancing drug discovery processes through advanced automation and artificial intelligence. This system is designed to streamline complex cell culture workflows, allowing researchers to focus on more critical tasks while improving efficiency and reliability.

What Are Latest Mergers And Acquisitions In The Automated Cell Cultures Market?

In February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, partnered with Celltrio Inc. to bring a fully automated cell culture system to biotherapeutics customers. By merging Thermo Fisher's Momentum software with Celltrio's RoboCell platform, the collaboration seeks to achieve fully automated cell line culturing. Celltrio Inc. is a US-based company that develops and delivers automation solutions for biobanking and cell line development processes.

What Defines the Automated Cell Cultures Market?

The automated cell cultures market consists of sales of automated bioreactors, cell culture platforms, and associated software for managing and analyzing cell growth and behavior. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Automated Cell Cultures Market Report 2026?

The automated cell cultures market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the automated cell cultures industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.